| Income Statement | 2025-09-30 | 2025-06-30 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
| Total other income (expense) | -1,444 | -1,263 | 2,933 | 2,018,911 |
| Income (loss) before income tax expense | -35,256 | -28,652 | -43,864 | 1,858,013 |
| Provision for income taxes | 0 | 2 | - | 2 |
| Net income (loss) | -35,256 | -28,654 | -43,864 | 1,858,011 |
| Basic (in dollars per share) | -2.28 | -1.85 | -2.84 | 127.1 |
| Basic (in shares) | 15,478,000 | 15,468,000 | 15,468,000 | 14,619,000 |
| Diluted (in dollars per share) | -2.28 | -1.85 | -2.84 | 125.48 |
| Diluted (in shares) | 15,478,000 | 15,468,000 | 15,468,000 | 14,807,000 |
Inhibrx Biosciences, Inc. (INBX)
Inhibrx Biosciences, Inc. (INBX)